HK1080087A1 - 心磷脂分子和其合成方法 - Google Patents

心磷脂分子和其合成方法

Info

Publication number
HK1080087A1
HK1080087A1 HK05112200.6A HK05112200A HK1080087A1 HK 1080087 A1 HK1080087 A1 HK 1080087A1 HK 05112200 A HK05112200 A HK 05112200A HK 1080087 A1 HK1080087 A1 HK 1080087A1
Authority
HK
Hong Kong
Prior art keywords
synthesis
cardiolipin molecules
cardiolipin
molecules
Prior art date
Application number
HK05112200.6A
Other languages
English (en)
Chinese (zh)
Inventor
Moghis U Ahmad
Murali K Ukkalam
Imran Ahmad
Original Assignee
Neopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/013917 external-priority patent/WO2004062569A2/fr
Priority claimed from PCT/US2003/016412 external-priority patent/WO2003099830A2/fr
Application filed by Neopharm Inc filed Critical Neopharm Inc
Publication of HK1080087A1 publication Critical patent/HK1080087A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
HK05112200.6A 2002-10-16 2005-12-30 心磷脂分子和其合成方法 HK1080087A1 (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41927702P 2002-10-16 2002-10-16
US42928502P 2002-11-26 2002-11-26
US43865903P 2003-01-07 2003-01-07
US46733103P 2003-05-02 2003-05-02
PCT/US2003/013917 WO2004062569A2 (fr) 2003-01-07 2003-05-04 Compositions de cardiolipine, leurs procedes de preparation et d'utilisation
PCT/US2003/016412 WO2003099830A2 (fr) 2002-05-24 2003-05-23 Compositions de cardiolipine, leurs procedes de preparation et d'utilisation
PCT/US2003/027806 WO2004039817A1 (fr) 2002-10-16 2003-09-05 Molecules de cardiolipine et procedes pour leur synthese

Publications (1)

Publication Number Publication Date
HK1080087A1 true HK1080087A1 (zh) 2006-04-21

Family

ID=32234368

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05112200.6A HK1080087A1 (zh) 2002-10-16 2005-12-30 心磷脂分子和其合成方法

Country Status (7)

Country Link
EP (2) EP1556392A1 (fr)
JP (2) JP2006510733A (fr)
AU (2) AU2003268478A1 (fr)
CA (2) CA2502285A1 (fr)
EA (2) EA200500659A1 (fr)
HK (1) HK1080087A1 (fr)
WO (2) WO2004039817A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815599B2 (en) 2004-06-01 2014-08-26 Pronai Therapeutics, Inc. Methods and compositions for the inhibition of gene expression
US20080286351A1 (en) * 2004-06-29 2008-11-20 Ahmad Moghis U Pegylated Cardiolipin Analogs, Methods of Synthesis, and Uses Thereof
WO2006052906A2 (fr) * 2004-11-08 2006-05-18 Neopharm, Inc. Synthese de produits analogues de la cardiolipine et leurs applications
WO2006113679A2 (fr) 2005-04-15 2006-10-26 Board Of Regents, The University Of Texas System Administration d'arnsi par compositions lipidiques neutres
WO2007014150A2 (fr) * 2005-07-22 2007-02-01 Neopharm, Inc. Procede d'administration de liposomes contenant des oligonucleotides
WO2007065017A2 (fr) * 2005-12-01 2007-06-07 Pronai Therapeutics, Inc. Systeme d'administration de liposomes cationiques a oligonucleotides
ES2419106T3 (es) 2005-12-01 2013-08-19 Pronai Therapeutics, Inc. Formulación de liposomas anfóteros
MX2008010826A (es) * 2006-02-24 2009-03-02 Neopharm Inc Metodo y proceso para preparar cardiolipina.
MX2011003207A (es) * 2008-09-27 2011-11-04 Jina Pharmaceuticals Inc Preparaciones farmaceuticas a base de lipidos para la aplicacion oral y topica; sus composiciones, metodos y usos.
AU2013246870B2 (en) * 2012-04-11 2016-06-23 Lipoxen Technologies Limited Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2113606A (en) * 1934-05-24 1938-04-12 Alba Pharmaceutical Company In Quaternary ammonium compounds
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
ATE383331T1 (de) * 1998-11-12 2008-01-15 Invitrogen Corp Transportreagentien
DE60016205T2 (de) * 1999-05-28 2005-12-01 Vical, Inc., San Diego Cytofectin-dimere und verfahren zu ihrer anwendung

Also Published As

Publication number Publication date
EP1556392A1 (fr) 2005-07-27
EA200500661A1 (ru) 2005-10-27
CA2502285A1 (fr) 2004-05-13
WO2004039817A1 (fr) 2004-05-13
AU2003268478A1 (en) 2004-05-25
WO2004039817A9 (fr) 2004-07-22
EA200500659A1 (ru) 2005-10-27
JP2006503112A (ja) 2006-01-26
AU2003277445A1 (en) 2004-05-04
WO2004035523A1 (fr) 2004-04-29
EP1558562A1 (fr) 2005-08-03
CA2501990A1 (fr) 2004-04-29
JP2006510733A (ja) 2006-03-30
WO2004035523B1 (fr) 2004-08-26

Similar Documents

Publication Publication Date Title
HK1080087A1 (zh) 心磷脂分子和其合成方法
IL166535A0 (en) Modified adamts4 molecules and method of use thereof
GB2392592B (en) Speech synthesis apparatus and method
EP1490579A4 (fr) Appareil et procede d'expansion de tubage
AU2003230957A8 (en) Quantitation of biological molecules
EP1567515A4 (fr) Nouveaux composes de lapachone et procedes d'utilisation correspondants
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
AU2003260291A8 (en) Proximity-aided synthesis of templated molecules
AU2003247276A8 (en) Methods and apparatuses for characterizing stability of biological molecules
EP1417628A4 (fr) Methodes informatisees d'identification de molecules
PL358247A1 (en) Pipette and method of making same
AU2003219824A1 (en) Fluorinated molecules and methods of making and using same
GB0213816D0 (en) Method of producing DNA and protein libraries
GB2401094B (en) Labels and methods of manufacture thereof
EP1484622A4 (fr) Prisme et procedure de fabrication correspondant
EP1491091A4 (fr) Moyen de resistance aux insectes et procede de resistance aux insectes
EP1590440A4 (fr) Molecules d'elimination de cellules et methodes d'utilisation associees
PL375184A1 (en) Method of enhancing multimedia
AU2003284344A8 (en) Labeling apparatus and method of making same
HUE039866T2 (hu) Az interferáló RNS molekulák további új formái
AU2003216354A8 (en) Modulators of paraptosis and related methods
GB0212853D0 (en) Separation of molecules
GB2392746B (en) Comparison of molecules using field points
AU2003261362A8 (en) Lipid binding molecules and methods of use
GB2407918B (en) Computer system and methods of using such system